Usana Health Sciences (USNA) Asset Writedowns and Impairment (2010 - 2026)

Usana Health Sciences (USNA) has reported Asset Writedowns and Impairment for 6 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment rose 7.27% year-over-year to $1.3 million; the TTM figure through Apr 2026 stood at $2.8 million (up 27.63% YoY), while the FY2026 annual figure was $2.7 million, up 41.67% from the prior year.
• Asset Writedowns and Impairment grew to $1.3 million in Q2 2026 per USNA's latest filing, from $264000.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $2.3 million in Q2 2023 and bottomed at -$3.1 million in Q4 2023.
• Historically, Asset Writedowns and Impairment has averaged $451461.5 across 4 years, with a median of $423000.0 in 2023.
• Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment sank 59.11% — and 2026, when it jumped 13100.0%.
• Usana Health Sciences' Asset Writedowns and Impairment stood at -$3.1 million in 2023, then jumped by 100.06% to $2000.0 in 2024, then surged by 18400.0% to $370000.0 in 2025, then surged by 251.08% to $1.3 million in 2026.
• Business Quant data shows USNA's Asset Writedowns and Impairment at $1.3 million in Q2 2026, $264000.0 in Q1 2026, and $370000.0 in Q3 2025.